Giving a neuromuscular blocking agent early in ARDS may improve survival
According to a study in the New England Journal of Medicine, administering a neuromuscular blocking agent for 48 hours at the onset of severe…
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.